PAUL DRINKA, M.D.; MAVIS SIEWERT, R.N.
This content is PDF only. Please click on the PDF icon to access.
To the editor: In the article on cost effectiveness of vaccination against pneumococcal pneumonia, Sisk and Riegelman (1) estimate that, at most, 20% to 35% of the recommended target group has been immunized. We write to share our successful approach to the administration of the pneumococcal vaccine in a nursing home. Our patient population invariably falls into the group of persons with chronic conditions that increase the risk of pneumococcal disease or who are age 65 and older. Our organization's approach has resulted in vaccination in a high percentage of patients for the last 5 years.
The Wisconsin Veterans Home
DRINKA P, SIEWERT M. Vaccination Against Pneumococcal Infection. Ann Intern Med. 1986;104:722–723. doi: https://doi.org/10.7326/0003-4819-104-5-722
Download citation file:
Published: Ann Intern Med. 1986;104(5):722-723.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use